CL Q2 2025

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Earnings

Colgate-Palmolive posted a solid if measured second quarter, beating Wall Street expectations on both the top and bottom lines as the consumer staples giant navigated a challenging cost environment. The company reported non-GAAP EPS of $0.92, edging … Read more Colgate-Palmolive posted a solid if measured second quarter, beating Wall Street expectations on both the top and bottom lines as the consumer staples giant navigated a challenging cost environment. The company reported non-GAAP EPS of $0.92, edging past the $0.89 consensus estimate by 2.80%, while revenue of $5.11 billion topped forecasts by 1.55% and grew 1.0% year over year. The headline beat was underpinned by organic sales growth of 1.8%, with strength in Africa/Eurasia, up 7.7% organically, and Hill's Pet Nutrition helping offset a 0.9% organic decline in North America, the company's weakest division. Gross profit margin compressed 50 basis points to 60.1%, pressured by higher raw material costs and tariff-related headwinds, a challenge Colgate is actively addressing through a new three-year productivity program targeting $200 million to $300 million in cumulative pre-tax savings through 2028. Looking ahead, management trimmed its organic sales growth outlook to the low end of its 2% to 4% range, while maintaining a low-single-digit EPS growth forecast for the full year.